BioNxt Solutions Inc.: BioNxt Reports Update on Commercializ

VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its transdermal

Related Keywords

Germany , Biberach , Baden Wüberg , United States , Vancouver , British Columbia , Canada , America , German , Hugh Rogers , Bionxt Rotigotine , Bionxt Solutions Inc , Company Rotigotine , Kuick Research , Bionxt Solutions Inc View , Precedence Research , European Medical Agency , Wissen Market Research , Bionxt Solutions , Vektor Pharma , Good Clinical Practice , Nxt Solutions , North America , Statement Regarding , Marcel Torney , Bionxt , Solutions , Reports , Update , Ommercialization , Otigotine , Watch , Treatment , Parkinson , Disease ,